H1 2022 Healthcare and Life Sciences in North America: Market Insights November 29, 2022 Life Science
Healthcare Roundup – Bristol Myers Squibb’s Inrebic nabs European Commission approval; Pfizer/BioNTech double the vaccine supply to EU February 8, 2021 Life Science
Healthcare Roundup – Lilly bamlanivimab combo therapy lowers COVID-19 hospitalizations, JNJ earnings release brightens U.S. biopharma outlook January 26, 2021 Life Science
Healthcare Roundup- Merck discontinues development of V590 and V591 COVID-19 vaccine candidates, Moderna’s COVID-19 jab retains neutralizing activity against emerging virus variants January 25, 2021 Life Science
Healthcare Roundup – Intuitive Surgical earns mixed reviews from analysts despite earnings beat; Amyris acquires Terasana Brand for offering clean cannabinoid consumer products January 22, 2021 Life Science
Healthcare Roundup – Moderna says dosing underway in Takeda-led early-stage COVID vaccine trial in Japan; Gene editors raise equity as shares climb amid investor interest January 21, 2021 Life Science
Healthcare Roundup – Adamis Pharma soars on Tempol IND submission for COVID-19 treatment; MindMed kicks off early stage trial for LSD-MDMA cocktail January 20, 2021 Life Science
Healthcare Roundup – Moderna drops as company acknowledges allergic reactions to COVID-19 shot, Eli Lilly upgraded to buy at Mizuho on positive donanemab data January 19, 2021 Life Science
Healthcare Roundup – COVID-19 Jabs: Israel trades data for doses; U.K. to vaccinate all adults by September；Grifols to trial new immunoglobulin therapy against COVID-19 January 18, 2021 Life Science
Technology Roundup – Xiaomi plunges 10% as U.S. adds smartphone giant to investment blacklist; Microsoft, Oracle, Salesforce are creating COVID vaccine passports January 15, 2021 Technology
Healthcare Roundup – The world will have to live with COVID forever; Gilead attributes long term growth to oncology franchise, excludes remdesivir January 14, 2021 Life Science
Healthcare Roundup – JNJ’s COVID-19 vaccine data published in Medical Journal, Evolus is up 6% after AbbVie-Cypris Medical deal January 14, 2021 Life Science
Healthcare Roundup – Gilead and VIR Biotechnology tie up in chronic hepatitis B virus cure setting, AstraZeneca’s COVID-19 vaccine is set for Indian rollout January 12, 2021 Life Science
Healthcare Roundup – JNJ’s single-dose COVID-19 vaccine viewed favorably by analysts; Eli Lilly up 20% after donanemab shows clinical benefit in mid-stage Alzheimer’s study January 12, 2021 Life Science
Healthcare Roundup – CVS raised as Jefferies sees meaningful earning surprises; SoftBank takes stake in Pacific Biosciences January 9, 2021 Life Science
Healthcare Roundup – Roche/Sanofi treatment combo improves survival rates in COVID-19；Dynavax’s Hepatitis B vaccine shows encouraging action in ongoing hemodialysis trial January 8, 2021 Life Science
